GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (FRA:UG2) » Definitions » Cyclically Adjusted Price-to-FCF

AngioDynamics (FRA:UG2) Cyclically Adjusted Price-to-FCF : 13.02 (As of May. 25, 2024)


View and export this data going back to 2013. Start your Free Trial

What is AngioDynamics Cyclically Adjusted Price-to-FCF?

As of today (2024-05-25), AngioDynamics's current share price is €5.60. AngioDynamics's Cyclically Adjusted FCF per Share for the quarter that ended in Feb. 2024 was €0.43. AngioDynamics's Cyclically Adjusted Price-to-FCF for today is 13.02.

The historical rank and industry rank for AngioDynamics's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:UG2' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 10.83   Med: 24.1   Max: 50.77
Current: 13

During the past years, AngioDynamics's highest Cyclically Adjusted Price-to-FCF was 50.77. The lowest was 10.83. And the median was 24.10.

FRA:UG2's Cyclically Adjusted Price-to-FCF is ranked better than
86.52% of 230 companies
in the Medical Devices & Instruments industry
Industry Median: 44.1 vs FRA:UG2: 13.00

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

AngioDynamics's adjusted free cash flow per share data for the three months ended in Feb. 2024 was €-0.377. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €0.43 for the trailing ten years ended in Feb. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AngioDynamics Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for AngioDynamics's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Cyclically Adjusted Price-to-FCF Chart

AngioDynamics Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.27 14.48 36.03 31.63 16.25

AngioDynamics Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.00 16.25 15.81 13.04 11.57

Competitive Comparison of AngioDynamics's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, AngioDynamics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AngioDynamics's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where AngioDynamics's Cyclically Adjusted Price-to-FCF falls into.



AngioDynamics Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

AngioDynamics's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=5.60/0.43
=13.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioDynamics's Cyclically Adjusted FCF per Share for the quarter that ended in Feb. 2024 is calculated as:

For example, AngioDynamics's adjusted Free Cash Flow per Share data for the three months ended in Feb. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=-0.377/130.9299*130.9299
=-0.377

Current CPI (Feb. 2024) = 130.9299.

AngioDynamics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201405 0.124 100.373 0.162
201408 0.002 100.352 0.003
201411 -0.103 99.635 -0.135
201502 0.196 99.032 0.259
201505 0.237 100.333 0.309
201508 0.099 100.548 0.129
201511 0.236 100.135 0.309
201602 0.289 100.040 0.378
201605 0.361 101.355 0.466
201608 0.169 101.617 0.218
201611 0.339 101.829 0.436
201702 0.353 102.779 0.450
201705 0.449 103.256 0.569
201708 0.058 103.587 0.073
201711 0.215 104.072 0.270
201802 0.057 105.052 0.071
201805 0.524 106.148 0.646
201808 -0.222 106.383 -0.273
201811 0.287 106.338 0.353
201902 0.175 106.649 0.215
201905 0.575 108.048 0.697
201908 -0.192 108.245 -0.232
201911 0.074 108.519 0.089
202002 -0.472 109.139 -0.566
202005 0.058 108.175 0.070
202008 -0.161 109.662 -0.192
202011 0.223 109.793 0.266
202102 0.097 110.968 0.114
202105 0.247 113.576 0.285
202108 -0.218 115.421 -0.247
202111 0.018 117.269 0.020
202202 -0.223 119.703 -0.244
202205 0.182 123.323 0.193
202208 -0.655 124.958 -0.686
202211 0.168 125.607 0.175
202302 0.004 126.928 0.004
202305 0.346 128.314 0.353
202308 -0.612 129.538 -0.619
202311 0.108 129.548 0.109
202402 -0.377 130.930 -0.377

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AngioDynamics  (FRA:UG2) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


AngioDynamics Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of AngioDynamics's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioDynamics (FRA:UG2) Business Description

Traded in Other Exchanges
Address
14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.

AngioDynamics (FRA:UG2) Headlines

No Headlines